This transaction
Acquisition of shares (making the company a subsidiary)The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.
Consulting services relating to the use and implementation of computers; research, development and sale of computer software; import and export of computer software; import and export of computers and peripheral equipment; leasing and rental of computer systems; placement of computer engineers; and manufacture and sale of medical devices, among other activities
The impact of the share acquisition on results for the fiscal year ending September 2026 is currently under internal review. If it becomes necessary to revise the earnings forecast, the Company will disclose the revision promptly.
| Item | Details |
|---|---|
| Transaction name | Acquisition of shares (making the company a subsidiary) |
| Counterparty name | Kudo Katsumi (工藤 克美), Kudo Tomomi (工藤 知実) |
| Name of the Subject Company | 株式会社プリズム・メディカル |
| Business Description of the Subject Company | Consulting services relating to the use and implementation of computers; research, development and sale of computer software; import and export of computer software; import and export of computers and peripheral equipment; leasing and rental of computer systems; placement of computer engineers; and manufacture and sale of medical devices, among other activities |
| Location of the Subject Company | Chuo-ku, Sapporo |
| Capital Stock of the Subject Company | ¥30 million |
| Date of Establishment of the Subject Company | January 1997 |
| Net Sales of the Subject Company | ¥131.141 million (fiscal year ended September 2025) |
| Operating Profit of the Subject Company | ¥15.386 million (fiscal year ended September 2025) |
| Net Income of the Subject Company | ¥11.916 million (fiscal year ended September 2025) |
| Net Assets of the Subject Company | ¥66.097 million (fiscal year ended September 2025) |
| Acquisition price | The acquisition price will not be disclosed pursuant to the confidentiality agreement with the counterparty. |
| Number of shares acquired | 3,000 shares (number of voting rights: 3,000) |
| Voting rights ownership percentage | Before 0.0% → after 100.0% |
| Impact on Business Performance | The impact of the share acquisition on results for the fiscal year ending September 2026 is currently under internal review. If it becomes necessary to revise the earnings forecast, the Company will disclose the revision promptly. |
| Date of board resolution | 14 July 2026 |
| Contract Date | 15 July 2026 |
| Execution Date / Effective Date | 31 July 2026 (planned) |
| Valuation methodology | The price was determined through discussions with the counterparty, taking into comprehensive consideration the results of financial due diligence, share valuation and legal due diligence conducted by external specialists. |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to bring プリズム into the Group, following its previous cooperation with the Company as an OEM partner, and integrate development, sales and maintenance. The Company cites faster product development, improved customer support capabilities, optimization of outsourcing costs, and greater stability in its earnings structure by bringing maintenance revenue in-house.